The role of serotonin in CNS function and in many neuropsychiatric diseases (e.g., schizophrenia, affective disorders, degenerative dementias) support the development of a reliable measure of serotonin receptor binding in vivo in human subjects. To this end, the regional distribution and intrasubjec
N.C.A. radiofluorination of altanserine a potential serotonine receptor-binding radiopharmaceutical for positron emission tomography
โ Scribed by C. Lemaire; R. Cantineau; L. Christiaens; M. Guillaume
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 103 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The highly potent serotonin (5โHT) uptake blocker, McNโ5652โZ (__trans__โ1,2,3,5,6,10b โ hexahydro โ 6 โ [4 โ (methylthio)phenyl] pyrrolo โ [2,1โa]โisoquinoline) was labeled with ^11^C for studying serotonin uptake sites using positron emission tomography (PET). [^11^C]McNโ5652โZ was sy
Carbon-11 labeled d-oxyphenonium iodide, a cholinergic antagonist is synthesized for in vivo visualization of muscarinic receptor-sites on airway tissue by positron emission tomography (PET). Methylation with [11C]CH3I of d-demethyloxyphenonium, followed by HPLC purification affords the desired radi
Tropapride, (exo)-2,3-dimethoxy-N-[8-(phenylmethyl)-8- azabicyclo[3.2.1]oct-3-yl]benzamide hydrochloride, has been labeled with fluorine-18 at the 2- and 4-positions of its benzylic group. Two synthetic pathways were investigated: the first one required the alkylation of the norbenzyl precursor with
The __N__โmethylโ dโaspartate (NMDA) receptor as a type of ionotropic glutamatergic receptors is essential for physiological processes such as learning, memory and synaptic plasticity. A glutamateโinduced overactivation of these receptors, accompanied by increased intracellular calcium concentration